133891-52-8

Usage

Uses

Used in Pharmaceutical Industry:
1-(DIPHENYLMETHYL)-3-METHYL-3-AZETIDINAMINE is used as an antihistamine for treating symptoms of allergies and the common cold, such as itching, sneezing, and runny nose, by blocking the action of histamine in the body.
Used in Sleep Aid Applications:
1-(DIPHENYLMETHYL)-3-METHYL-3-AZETIDINAMINE is utilized as a sleep aid due to its sedative effects, helping to induce sleep and improve rest for individuals experiencing insomnia or other sleep disturbances.
However, it is important to note that due to its potential to cause drowsiness, 1-(DIPHENYLMETHYL)-3-METHYL-3-AZETIDINAMINE should be used with caution, particularly when engaging in activities that require alertness such as operating heavy machinery or driving.

Upstream product

• 40320-63-6 1-benzhydryl-3-methylazetidin-3-ol 
• 133891-87-9 methanesulfonic acid 1-benzhydryl-3-methylazetidin-3-yl ester 

Downstream Products

• 1613720-10-7 6-(1-benzhydryl-3-methylazetidin-3-ylamino)-4-methyl-7-trifluoromethyl-2-(2-trimethylsilanylethoxymethyl)-2,10-dihydro-9-oxa-1,2,4a-triazaphenanthren-3-one 
• 920320-54-3 (1-benzhydryl-3-methyl-azetidin-3-yl)-carbamic acid tert-butyl ester 
• 124668-47-9 3-methyl-3-aminoazetidine dihydrochloride 

Relevant academic research and scientific papers

ANTAGONISTS OF SNS SODIUM CHANNELS

Compounds of the formula (I), and pharmaceutically acceptable salts thereof, are found to be antagonists of SNS sodium channels. They are therefore useful as analgesic and neuroprotective agents, formula (I): R1 represents: (a) -L-A or -L' -A'

7-Azetidinylquinolones as antibacterial agents. Synthesis and structure- activity relationships

A series of novel antibacterial quinolones and naphthyridones has been prepared which contain 7-azetidinyl substituents in place of the usual piperazine or aminopyrrolidine groups. These azetidinyl derivatives were evaluated for in vitro activity by deter

Quantitative structure-activity relationships of antibacterial agents, 7-heterocyclic amine substituted 1-cyclopropyl-6,8-difluoro-4-oxoquinoline-3-carboxylic acids

Quantitative structure-activity relationships (QSAR) of various 7-(3-substituted-azetidin-1-yl)-1-cyclopropyl-6,8-difluoro-1,4-dihydro -4-oxoquinoline-3-carboxylic acids, 14-25, were studied to clarify the structural requirements for 3-substituted azetidi

Substituted 1-diphenylmethyl azetidines

New azetidines, characterized in that they correspond to the general formula (I) STR1 in which R3 represents an amino radical, an alkylamino radical, a dialkylamino radical, a cycloalkylamino radical, an acylamino radical, an alkylacylamino radical, an aminomethyl radical, an alkylaminomethyl radical, an acylaminomethyl radical or an alkylacylaminomethyl radical, in which radicals each acyl fragment may be substituted with one or more halogen, especially fluorine, atoms; and R1, R2, R4, R5 and R6 represent a hydrogen atom or a lower alkyl radical, with the proviso that at least one of them represents a lower alkyl radical, and also their salts.